Fig. 4From: Elevated MR-proANP plasma concentrations are associated with sepsis and predict mortality in critically ill patientsMR-proANP is a biomarker for mortality in critically ill patients a Patients that died during or after ICU treatment displayed significant higher MR-proANP levels at ICU admission compared to patients that survived in the long-term follow-up. b High vs. low MR-proANP plasma concentrations discriminated survival of the critically ill patients, as displayed by Kaplan–Meier survival curve analysis for MR-proANP separated into quartiles. c Elevated MR-proANP plasma concentrations at ICU admission (optimal cut-off: 227.0 pmol/l) predicted the overall mortality in critically ill patients. p-values (U-test or log rank test) are givenBack to article page